Cargando…
Hemophilia management: Huge impact of a tiny difference
Hemophilia A and B are inherited X‐linked disorders of hemostasis, associated with an increased bleeding tendency. Patients with severe hemophilia have undetectable clotting factor levels and experience spontaneous bleeds. In patients with nonsevere hemophilia, the clotting factor levels are 2% to 4...
Autores principales: | Kloosterman, Fabienne, Zwagemaker, Anne‐Fleur, Abdi, Amal, Gouw, Samantha, Castaman, Giancarlo, Fijnvandraat, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086468/ https://www.ncbi.nlm.nih.gov/pubmed/32211572 http://dx.doi.org/10.1002/rth2.12314 |
Ejemplares similares
-
Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia
por: Shima, Midori
Publicado: (2020) -
Phosphatidylinositol 3‐monophosphate: A novel actor in thrombopoiesis and thrombosis
por: Valet, Colin, et al.
Publicado: (2020) -
Hematologic concerns in extracorporeal membrane oxygenation
por: Sniderman, Jonathan, et al.
Publicado: (2020) -
Platelet CLEC‐2 and lung development
por: Suzuki‐Inoue, Katsue, et al.
Publicado: (2020) -
Plasminogen activation in the musculoskeletal acute phase response: Injury, repair, and disease
por: Gibson, Breanne H.Y., et al.
Publicado: (2020)